Abstract Number: 875 • ACR/ARHP Annual Meeting 2012
Discovery of Pharmacologic MIF Antagonists by Structure-Based Molecular Design
Background/Purpose: Cytokine inhibition is becoming a mainstay for the therapy of autoimmunity but current antibody-based approaches remain limited by high cost, parenteral administration, and anti-idiotype…
ACR Meeting Abstracts